Mylan NV may be significantly overcharging patients for its EpiPen allergy shot. Since Mylan acquired the drug in 2007, the price has increased six-fold, from $100 to $600 for two doses. Yet Mylan pays only $34.50 per pen.
Pharmacy Benefit Managers (PBMs) have a lot of influence in the prescription drug industry—they directly affect the costs of your medications—but many consumers are unfamiliar with these health-industry intermediaries. Here are five things to ...
Keller Rohrback L.L.P., on behalf of the City of Tacoma, filed suit against Purdue Pharma, Endo Pharmaceuticals and Janssen Pharmaceuticals, three of the biggest manufacturers of prescription opioids in the United States.
